Janus Henderson Group’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$494K Hold
20,106
﹤0.01% 2011
2025
Q4
$499K Hold
20,106
﹤0.01% 2022
2025
Q3
$569K Hold
20,106
﹤0.01% 1948
2025
Q2
$500K Hold
20,106
﹤0.01% 1950
2025
Q1
$615K Hold
20,106
﹤0.01% 1854
2024
Q4
$633K Hold
20,106
﹤0.01% 1921
2024
Q3
$1.16M Sell
20,106
-4,700
-19% -$231K ﹤0.01% 1586
2024
Q2
$1.01M Buy
24,806
+6,058
+32% +$240K ﹤0.01% 1614
2024
Q1
$786K Buy
18,748
+38
+0.2% +$1.48K ﹤0.01% 1783
2023
Q4
$715K Sell
18,710
-4
-0% -$133 ﹤0.01% 1825
2023
Q3
$577K Sell
18,714
-48
-0.3% -$1.66K ﹤0.01% 1852
2023
Q2
$593K Sell
18,762
-12
-0.1% -$411 ﹤0.01% 1885
2023
Q1
$684K Buy
+18,774
New +$657K ﹤0.01% 1846
2022
Q3
Sell
-6,240
Closed -$241K 2576
2022
Q2
$241K Buy
6,240
+100
+2% +$3.8K ﹤0.01% 2217
2022
Q1
$297K Buy
6,140
+3
+0% +$155 ﹤0.01% 2229
2021
Q4
$451K Buy
6,137
+3,093
+102% +$254K ﹤0.01% 1955
2021
Q3
$277K Buy
+3,044
New +$259K ﹤0.01% 1934

Other funds holding ASTH

Janus Henderson Group's ASTH Position: Q1 2026 in Review

Janus Henderson Group held its Astrana Health (ASTH) position steady in Q1 2026 at 20,106 shares worth $494K. The position accounts for ﹤0.01% of the portfolio, ranked #2011.

Janus Henderson Group first reported a position in ASTH in Q3 2021 and has held it in 17 quarters since. The position peaked at $1.16M in Q3 2024. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Janus Henderson Group held 20,106 shares of Astrana Health worth $494K as of Q1 2026.
  • Janus Henderson Group left its Astrana Health share count unchanged in Q1 2026.
  • Astrana Health made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2011 holding.
  • Janus Henderson Group first reported a position in Astrana Health in Q3 2021 and has held it in 17 quarters since.
  • Janus Henderson Group's Astrana Health position peaked at $1.16M in Q3 2024.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.